本页面由Tiger Trade Technology Pte. Ltd.提供服务

Stoke Therapeutics, Inc.

32.85
-0.8500-2.52%
盘后32.850.00000.00%17:10 EDT
成交量:50.06万
成交额:1,650.66万
市值:19.43亿
市盈率:-282.55
高:34.54
开:33.79
低:32.36
收:33.70
52周最高:40.22
52周最低:5.35
股本:5,915.08万
流通股本:4,393.78万
量比:0.34
换手率:1.14%
股息:- -
股息率:- -
每股收益(TTM):-0.1163
每股收益(LYR):-0.1163
净资产收益率:-2.37%
总资产收益率:-3.73%
市净率:5.51
市盈率(LYR):-282.55

数据加载中...

2025/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/13

重要事件披露

Form 8-K - Current report
2025/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/18

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/18

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/18

重要事件披露

Form 8-K - Current report
2025/02/19

重要事件披露

Form 8-K - Current report
2025/01/07

重要事件披露

Form 8-K - Current report
2024/12/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/06

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/05

重要事件披露

Form 8-K - Current report
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/23

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

重要事件披露

Form 8-K - Current report